# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
SOC Telemed (NASDAQ:TLMD) has observed the following analyst ratings within the last quarter:
Credit Suisse analyst Jailendra Singh maintains SOC Telemed (NASDAQ:TLMD) with a Neutral and raises the price target from $2...
SOC Telamed (TLMD) Exela Technologies (XELA) Senseonics (SENS) Applied Genetic Technologies (AGTC) Reed's (REED) Cit...
Benchmark analyst Bill Sutherland downgrades SOC Telemed (NASDAQ:TLMD) from Buy to Hold.
RBC Capital analyst Sean Dodge downgrades SOC Telemed (NASDAQ:TLMD) from Outperform to Sector Perform and lowers the price t...
Baird analyst Vikram Kesavabhotla downgrades SOC Telemed (NASDAQ:TLMD) from Outperform to Neutral and lowers the price targe...